BACKGROUND: Warfarin is effective for stroke prevention in atrial fibrillation (AF), but
anticoagulation is underused in clinical care. The risk of venous thromboembolic disease …

Background Although many patients with venous thromboembolism require extended
treatment, it is uncertain whether it is better to use full-or lower-intensity anticoagulation …

Introduction: Gastrointestinal bleeding (GIB) is a major problem in patients on oral
anticoagulation therapy. This issue has become even more pressing since the introduction …

Aims Novel oral anticoagulants (NOACs) are alternatives to vitamin‐K antagonists (VKAs)
for the prevention of thromboembolism. It is unclear how NOACs have been adopted in the …

Pulmonary embolism (PE) is a common, potentially fatal thrombotic disease. Atrial fibrillation
(AF), the most common arrhythmia, may also lead to thromboembolic complications …

Persons aged≥ 65 years not only account for over 60% of venous thromboembolism (VTE)
events, they have also a higher mortality and VTE-related morbidity than younger patients …

Background Currently, little evidence is available on the length and type of anticoagulation
used for extended treatment for prevention of recurrent venous thromboembolism (VTE) in …

Venous thromboembolism (VTE) contributes to significant morbidity, mortality, and
socioeconomic burden. There is a paucity of literature regarding sex-based …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but life-threatening form
of pulmonary artery hypertension that is defined as a mean arterial pulmonary pressure …

Modern diagnostic strategies for pulmonary embolism diagnosis almost all rely on an initial
assessment of the pretest probability. Clinical prediction rules are decision-making tools …